PEGylated lipid polymeric nanoparticle–encapsulated acyclovir for in vitro controlled release and ex vivo gut sac permeation
Currently, pharmaceutical research is directed wide range for developing new drugs for oral administration to target disease. Acyclovir formulation is having common issues of short half-life and poor permeability, causing messy treatment which results in patient incompliance. The present study form...
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Článek |
| Jazyk: | English |
| Vydáno: |
Springer Science and Business Media Deutschland GmbH
2020
|
| Témata: | |
| On-line přístup: | http://umpir.ump.edu.my/id/eprint/30858/1/AAPS%20PharmSciTech%202020%2021%20285.pdf |